NCT04222972 2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3 Terminated
Hoffmann-La Roche
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Nektar Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Duke University
University of Florida
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
SCRI Development Innovations, LLC